Baker-Polito Administration Announces $19.5 Million Job Creation Incentives for 28 Massachusetts Life Sciences Companies
Baker-Polito Administration Announces $19.5 Million Job Creation Incentives for 28 Massachusetts Life Sciences Companies
Life Sciences Center Taking Lead on Women’s Health Initiative
From high blood pressure, to depression, to autoimmune conditions, women are suffering at higher rates from many illnesses and diseases. Furthermore, exclusion of women from clinical trials and a lack...
Read MoreNo Treatment Left Behind: Reboot Rx Aiming to Save Lives with Overlooked Generic Drugs and AI Technology
How can we get more treatment options to cancer patients who need them? Moreover, can we do it faster and make it more affordable? Most everyone has themselves or knows...
Read MoreThe MLSC Joins Industry Leaders in Support of MassBioEd’s Life Sciences Apprenticeship Program
Today, the Massachusetts Life Sciences Center (MLSC) announced its support of the Massachusetts Biotechnology Education Foundation’s (MassBioEd) Life Sciences Apprenticeship program with a $50,000 grant. The program will support underrepresented...
Read MoreMassBioEd Launches Novel Life Sciences Apprenticeship Program Statewide
The Massachusetts Biotechnology Education Foundation (“MassBioEd”) has launched a new Life Sciences Apprenticeship program. The program, believed to be the first of their kind in the United States, is designed...
Read MoreTufts Scientists Receive Grants from Massachusetts Life Sciences Center
Three Tufts scientists and their teams have received capital funding this month from the Massachusetts Life Sciences Center (MLSC) to support research ranging from drug delivery to disease detection technologies....
Read MoreMLSC Launches 2021-2022 Capital Programming Round
The MLSC is excited to announce that it is accepting applications for this year’s capital programs: Bits to Bytes, Novel Therapeutics Delivery, Women’s Health, and Research Infrastructure. The deadline to...
Read MoreAXONIS Therapeutics Announces $5 Million in Funding; Provides Update on Progress Advancing Novel Therapeutics for Neurological Disorders
AXONIS Therapeutics, Inc., an emerging biotechnology company advancing breakthrough research to develop therapies for neurological disorders, today announced it has secured an additional $5 million in funding. This financing round,...
Read MoreKephera Diagnostics launches CLIA test for quantitative antibody response to COVID-19 vaccination
Kephera Diagnostics announced today the launch of a quantitative test to measure the level of antibodies elicited by vaccination against COVID-19, as well as by COVID-19 infection. The test will...
Read More